Weight
|
BMI ≥30, weight gain >5%
|
Antipsychotic management
|
Switch to medication w/ lower propensity for weight gain
|
VA dataset
|
Lifestyle modification
|
Counseling on diet, exercise, and behavior modification within 30 days, OR
|
Chart review
|
Nutrition consult within 30 days, OR
|
VA dataset
|
‘MOVE!’ Program encounter(s) within 30 days
|
VA dataset
|
Medication
|
Orlistat prescription within 30 days
|
VA dataset
|
Glucose
|
Plasma glucose ≥200 or Hgb A1c ≥6.5
|
Antipsychotic management
|
Switch to medication with lower propensity for elevated glucose
|
VA dataset
|
Lifestyle modification
|
Counseling on diet, exercise, and behavior modification within 30 days, OR
|
Chart review
|
Nutrition consult within 30 days, OR
|
VA dataset
|
‘MOVE!’ Program encounter(s) within 30 days
|
VA dataset
|
Follow-up
|
Primary care/diabetes clinic visit within 30 days
|
VA dataset
|
Medication
|
Hypoglycemic agent within 30 days
|
VA dataset
|
Lipids
|
LDL ≥160
|
Antipsychotic management
|
Switch to medication w/ lower propensity for elevated lipids
|
VA dataset
|
Lifestyle modification
|
Counseling on diet, exercise, and behavior modification within 30 days, OR
|
Chart review
|
Nutrition consult within 30 days, OR
|
VA dataset
|
‘MOVE!’ Program encounter(s) within 30 days
|
VA dataset
|
Follow-up
|
Primary care/medicine visit within 30 days
|
VA dataset
|
Medication
|
Statin prescription within 30 days
|
VA dataset
|